Bristol-Myers Squibb Co. (NYSE:BMY) is a global biopharmaceutical company. The company has a market cap of $56.57 billion. It is expected to report FY 2012 fourth-quarter EPS of 43 cents on revenue of $4.14 billion, compared with a profit of 53 cents a share on revenue of $5.45 billion in the year-ago period. The analysts' consensus full-year forecast calls for EPS of $1.96 on revenue of $17.57 billion. That compares to $2.28 per share and $21.24 billion in the previous year. Bristol-Myers Squibb is trading around $34.27 a share. Over the past 12 months, the stock has gained 1.4 percent.